US 10988778
Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders
granted A61KA61K33/34A61K38/46
Quick answer
US patent 10988778 (Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K33/34, A61K38/46, A61K48/005, A61P